Study, Mar./17: "Effects of selective serotonin reuptake inhibitors on glaucoma"

"CONCLUSION:  Treatment with SSRIs was associated with greater risk of having a diagnosis of glaucoma, particularly in individuals with longer duration and/or higher average dose of SSRI. Our findings suggest that individuals receiving SSRIs treatment for extended periods of time and/or at relatively higher therapeutic doses should be monitored for symptoms associated with glaucoma."

https://www.ncbi.nlm.nih.gov/pubmed/28257449